Recent Updates
Recently added Catalysts
PTCT Positive Sentiment

PTC Therapeutics to Participate in Upcoming Investor Conferences

Key Takeaway: PTC Therapeutics, Inc. announced its participation in two upcoming investor conferences. Executives will speak at the Jefferies Global Healthcare Conference on Nov. 16 and the Citi 2026 Global Healthcare Conference on Dec. 1. The presentations will be available for live streaming and archived for 30 days.

Market Sentiment Analysis

POSITIVE FACTORS

  • Executives will present at multiple investor conferences.
  • Presentations will be available via live webcast.
  • PTC is focused on rare disorders and unmet medical needs.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+74%
120-day peak, hindsight
Typical move
4.2%
average across 6 past catalysts
Cash runway
~252 mo
Minimal dilution risk
Lead asset
Vatiquinone
Phase 3 · Friedreich Ataxia

Full Press Release Details

WARREN, N.J., Nov. 2, 2026 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that its executives will speak at the following conferences:

Jefferies Global Healthcare Conference Monday, Nov. 16 at 11 a.m. GMT/6 a.m. ET

Citi 2026 Global Healthcare Conference Tuesday, Dec. 1 at 9:40 a.m. ET

The presentations will be webcast live on the Events and Presentations page under the Investor section of the PTC Therapeutics website at https://ir.ptcbio.com/events-presentations and will be archived for 30 days following the presentation.
About PTC Therapeutics, Inc. PTC is a global biopharmaceutical company dedicated to the discovery, development and commercialization of clinically differentiated medicines for children and adults living with rare disorders. PTC is advancing a robust and diversified pipeline of transformative medicines as part of its mission to provide access to best-in-class treatments for patients with unmet medical needs. The company's strategy is to leverage its scientific expertise and global commercial infrastructure to optimize value for patients and other stakeholders. To learn more about PTC, please visit www.ptcbio.com and follow us on LinkedIn, X, Facebook and Instagram.

Investors: Ellen Cavaleri +1 (615) 618-6228 ecavaleri@ptcbio.com

Media: Jeanine Clemente +1 (908) 912-9406 jclemente@ptcbio.com

Frequently Asked Questions

When will PTC present at the Jefferies conference?

PTC will present at the Jefferies Global Healthcare Conference on Nov. 16.

How can I watch PTC's presentations?

The presentations will be webcast live on PTC's website.

What is the focus of PTC Therapeutics?

PTC focuses on developing treatments for rare disorders.

How long will the webcasts be available?

The webcasts will be archived for 30 days after the presentations.

Last updated: Nov 2, 2026